| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2018 | Dec 17, 2018 | Ballance David James VP Research Sci. Affairs | Buy | Phasebio Pharmaceuticals Inc | PHAS | $3.94 | $3,940 | +11.63% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.